Thursday, December 21, 2006 8:00:00 AM PDT | VentureDeal Staff
PA -- RedPath Integrated Pathology announced the
closing of a series A round of financing totaling $6.5 million.
Investors in the round included Seneca Health Partners, Inflexion Partners, HMA
Capital Partners, New Spring Capital and CID Capital.
RedPath is a national specialty laboratory that provides complex cancer testing
services. The company intends to use the funds to increase its sales and
marketing efforts and scale its operations.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
Founded in 2006, VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.
Learn More »
© VentureDeal, Inc., Menlo Park, CA. All Rights Reserved.